Key terms
About CHE
Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CHE news
Apr 25
7:55am ET
Chemed (CHE) Receives a Rating Update from a Top Analyst
Apr 25
7:20am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: SI-Bone (SIBN), Conmed (CNMD) and Chemed (CHE)
Apr 24
4:25pm ET
Chemed backs FY24 adjusted EPS view $23.30-$23.70, consensus $23.52
Apr 24
4:25pm ET
Chemed reports Q1 adjusted EPS $5.20, consensus $5.48
Apr 17
10:06am ET
VITAS completes purchase of assets in Florida, Alabama
Apr 09
11:50am ET
Analysts Conflicted on These Healthcare Names: Chemed (CHE) and Alkermes (ALKS)
Mar 14
5:50am ET
Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Ionis Pharmaceuticals (IONS) and Arcellx Inc (ACLX)
Mar 04
10:11am ET
Chemed price target raised to $712 from $604 at RBC Capital
Feb 29
8:41am ET
Chemed price target raised to $650 from $625 at Oppenheimer
Feb 29
5:50am ET
Analysts’ Top Healthcare Picks: Amgen (AMGN), Sarepta Therapeutics (SRPT)
Feb 28
7:50am ET
Analysts Offer Insights on Healthcare Companies: Radnet (RDNT), Chemed (CHE) and UnitedHealth (UNH)
No recent press releases are available for CHE
CHE Financials
Key terms
Ad Feedback
CHE Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CHE Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range